Literature DB >> 27662880

Targeted Gene Activation Using RNA-Guided Nucleases.

Alexander Brown1, Wendy S Woods1, Pablo Perez-Pinera2.   

Abstract

The discovery of the prokaryotic CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR-associated) system and its adaptation for targeted manipulation of DNA in diverse species has revolutionized the field of genome engineering. In particular, the fusion of catalytically inactive Cas9 to any number of transcriptional activator domains has resulted in an array of easily customizable synthetic transcription factors that are capable of achieving robust, specific, and tunable activation of target gene expression within a wide variety of tissues and cells. This chapter describes key experimental design considerations, methods for plasmid construction, gene delivery protocols, and procedures for analysis of targeted gene activation in mammalian cell lines using CRISPR-Cas transcription factors.

Entities:  

Keywords:  CRISPR-Cas9; Gene activation; Gene expression; Genome engineering; RNA-guided nucleases; Synthetic biology; Transcription

Mesh:

Substances:

Year:  2017        PMID: 27662880     DOI: 10.1007/978-1-4939-4035-6_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Prosurvival long noncoding RNA PINCR regulates a subset of p53 targets in human colorectal cancer cells by binding to Matrin 3.

Authors:  Ritu Chaudhary; Berkley Gryder; Wendy S Woods; Murugan Subramanian; Matthew F Jones; Xiao Ling Li; Lisa M Jenkins; Svetlana A Shabalina; Min Mo; Mary Dasso; Yuan Yang; Lalage M Wakefield; Yuelin Zhu; Susan M Frier; Branden S Moriarity; Kannanganattu V Prasanth; Pablo Perez-Pinera; Ashish Lal
Journal:  Elife       Date:  2017-06-05       Impact factor: 8.140

2.  Multiplexed and tunable transcriptional activation by promoter insertion using nuclease-assisted vector integration.

Authors:  Alexander Brown; Jackson Winter; Michael Gapinske; Nathan Tague; Wendy S Woods; Pablo Perez-Pinera
Journal:  Nucleic Acids Res       Date:  2019-07-09       Impact factor: 16.971

Review 3.  CRISPR-based strategies in infectious disease diagnosis and therapy.

Authors:  Alexandra Binnie; Emanuel Fernandes; Helder Almeida-Lousada; Ramon Andrade de Mello; Pedro Castelo-Branco
Journal:  Infection       Date:  2021-01-03       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.